Logo

Nebula Genomics

ProPhase Labs to Repurchase $6M of Common Stock

The company plans to repurchase up to $6 million of its common shares over a six-month period, which the company's board will periodically reevaluate.

ProPhase Labs Acquires Personal Genome Sequencing Firm Nebula Genomics for $14.6M

Nebula, cofounded by George Church in 2017, offers a whole-genome sequencing test directly to consumers that provides diagnostic-ready data.

Nebula Genomics, Oasis Labs Partner to Offer Secure Personal Genomic Data

Data privacy firm Oasis Labs will offer a consumer-controlled data management app to customers of the DNA testing company, which was cofounded by George Church.

Nebula Genomics Inks Deal With EMD Serono To Help Enable Personal Genome Sequencing
Premium

In a pilot study, EMD Serono will have the genomes of lung cancer patients sequenced for research but participants will also gain access to their genomic data.

With Mapmygenome Deal, DNATix Continues Blockchain Ecosystem Rollout
Premium

Israeli firm DNATix recently claimed not only the transfer of a genetic sequence using blockchain technology, but the transfer of a complete Y chromosome.

Breaking News
The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.